Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ICUI

ICUI - ICU Medical Inc Stock Price, Fair Value and News

$125.92-2.86 (-2.22%)
Delayed

42/100

ICUI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

42/100

ICUI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ICUI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ICUI Price Action

Last 7 days

-4.6%

Last 30 days

-14.8%

Last 90 days

-15.2%

Trailing 12 Months

-10.2%

ICUI RSI Chart

ICUI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ICUI Valuation

Market Cap

3.1B

Price/Earnings (Trailing)

4.2K

Price/Sales (Trailing)

1.39

EV/EBITDA

33.71

Price/Free Cashflow

33.87

ICUI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

ICUI Fundamentals

ICUI Revenue

Revenue (TTM)

2.2B

Rev. Growth (Yr)

-14.15%

Rev. Growth (Qtr)

0.69%

ICUI Earnings

Earnings (TTM)

732.0K

Earnings Growth (Yr)

33.97%

Earnings Growth (Qtr)

-363.31%

ICUI Profitability

Operating Margin

34.76%

EBT Margin

0.20%

Return on Equity

0.03%

Return on Assets

0.02%

Free Cashflow Yield

2.95%

ICUI Investor Care

Shares Dilution (1Y)

0.70%

Diluted EPS (TTM)

0.03

ICUI Alerts

  • Big fall in Revenue (Y/Y)
  • Big jump in Earnings (Y/Y)
  • Losses in recent quarter

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.4B2.4B2.3B2.2B
20242.3B2.3B2.3B2.4B
20232.3B2.3B2.2B2.3B
20221.5B1.8B2.0B2.3B
20211.3B1.3B1.3B1.3B
20201.3B1.3B1.3B1.3B
20191.4B1.3B1.3B1.3B
20181.4B1.4B1.4B1.4B
2017537.3M772.0M1.0B1.3B
2016350.0M363.0M374.1M379.4M
2015317.5M322.6M331.2M341.7M
2014312.6M312.7M307.3M309.3M
2013315.7M317.0M318.4M313.7M
2012306.2M305.7M310.7M316.9M
2011290.7M299.9M300.9M302.2M
Get all data in R, Python etc through our Historical Stock Data APIs

About ICU Medical Inc

ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
 CEO
 WEBSITEicumed.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES14500

ICU Medical Inc Frequently Asked Questions

ICUI is the stock ticker symbol of ICU Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of ICU Medical Inc is 3.11 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, ICUI's PE ratio (Price to Earnings) is 4.25 Thousand and Price to Sales (PS) ratio is 1.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ICUI PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, ICU Medical Inc has provided 0.028 (multiply by 100 for percentage) rate of return.